Please login to the form below
lipodystrophy
This page shows the latest lipodystrophy news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: European approvals for BMS' Opdivo, Aegerion's lipodystrophy treatment, Pfizer's biosimilar and Xeljanz
Patients with lipodystrophy have previously relied on lifestyle changes and medications, like insulin injections to manage the condition’s associated complications. ... Today’s milestone marks a significant change in the way lipodystrophy is treated.
Latest news
-
Safety issues dampen enthusiasm for Akcea's volanesorsen
The company is upbeat about the prospects for the drug, which is also being developed for familial partial lipodystrophy (FPL), another rare disease characterised by elevated triglyceride levels.
-
Isis renamed Ionis to sidestep militant association
is in trials for familial chylomicronaemia syndrome and familial partial lipodystrophy.
-
R&D productivity takes off
lipodystrophy - now divested to Aegerion Pharmaceuticals - has been set at an eye-watering $325, 000 a year.
-
Sharing good diabetes practice in the NHS
In this case the judges decided that the National Severe Insulin Resistance Service, a new national clinical service for patients with severe insulin resistance and/or lipodystrophy, was a worthy winner
-
Nexium windfall lifts AZ in third quarter
Meanwhile, AZ also said it is selling Myalept (metreleptin), an approved drug for generalised lipodystrophy, to Aegerion Pharmaceuticals.
More from news
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Choices, choices: the rapidly evolving HIV treatment landscape
Since the advent of ARVs, the life expectancy of HIV patients has increased to be on par with those unaffected; however, long-term side-effects associated with NRTIs include lipodystrophy, kidney
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
- Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
- Send Us a Message
- Pharma, Technology, and Healthcare in the New Normal
- Solving the Caregiver Crisis Through Technology
- Therapeutic VR for Managing Pain & Improving Patient Outcomes
- Fishawack Health launches global ‘PsoriasIS NOT CONTAGIOUS’ mask campaign for World Psoriasis Day 2020
- The impact of COVID-19 on cancer care
- UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- The science of the deal
- Business development is more like child-raising than you might think...
- The other side of … rheumatoid arthritis
- For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
- How to lessen site burden with a targeted patient recruitment strategy
- Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Quick links
Infographics
